Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04040244 · ClinicalTrials.gov registry record · NA
Exhaled Breath Analysis to Predict Risk of Symptomatic Pneumonitis
A NA study, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT04040244 is a NA study that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 16 participants.
The verdict
NCT04040244, a NA study, was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
This is a prospective pilot study investigating exhaled breath condensate analyses to quantify the variability over time of various biomarkers associated with symptomatic pneumonitis.
Interventions
- OTHER Blood sample
- OTHER Exhaled Breath Collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2019-12-09 |
| Est. Completion | 2022-03-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04040244
The ClinicalTrials.gov registry entry for NCT04040244 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Blood sample is the first listed.
NCT04040244 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04040244 about?
NCT04040244 is a clinical study titled "Exhaled Breath Analysis to Predict Risk of Symptomatic Pneumonitis". This is a prospective pilot study investigating exhaled breath condensate analyses to quantify the variability over time of various biomarkers associated with symptomatic pneumonitis.
What is the current status of trial NCT04040244?
This trial is currently terminated. It is a NA study. The enrollment target is 16 participants. The study started on 2019-12-09. Estimated completion is 2022-03-10.
What interventions are being tested in trial NCT04040244?
The interventions under investigation include: Blood sample (OTHER), Exhaled Breath Collection (OTHER).
Who is sponsoring clinical trial NCT04040244?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.